Tetraphase Pharmaceuticals (TTPH) in Focus: Stock Up 5.5% – Tale of the Tape

The stock witnessed one downward estimate revision in the past 30 days. The Zacks Consensus Estimate also moved down over the same time frame, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Tetraphase Pharmaceuticals carry a Zacks Rank #4 (Sell), while its Earnings ESP is Positive.

However, some better-ranked stocks in the med-drugs industry include Hyperion Therapeutics, Inc. (HPTX), Lannett Company, Inc. (LCI) and Aeolus Pharmaceuticals Inc. (AOLS). While Hyperion Therapeutics and Lannett Company sport a Zacks Rank #1 (Strong Buy), Aeolus Pharmaceuticals holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>